RIZZI, Federica Maria Angela
 Distribuzione geografica
Continente #
NA - Nord America 5.615
AS - Asia 4.950
EU - Europa 3.617
SA - Sud America 574
AF - Africa 229
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.003
Nazione #
US - Stati Uniti d'America 5.452
SG - Singapore 1.553
CN - Cina 1.332
VN - Vietnam 1.005
IT - Italia 878
IE - Irlanda 585
BR - Brasile 435
SE - Svezia 432
FI - Finlandia 363
HK - Hong Kong 324
DE - Germania 286
UA - Ucraina 232
FR - Francia 206
BD - Bangladesh 183
ZA - Sudafrica 148
NL - Olanda 136
RO - Romania 120
CA - Canada 115
TR - Turchia 103
IN - India 94
GB - Regno Unito 92
AT - Austria 80
RU - Federazione Russa 66
AR - Argentina 49
KR - Corea 41
ID - Indonesia 40
IR - Iran 40
JP - Giappone 34
IQ - Iraq 31
BE - Belgio 30
PH - Filippine 29
MX - Messico 23
PK - Pakistan 22
CO - Colombia 21
EC - Ecuador 20
CZ - Repubblica Ceca 19
ES - Italia 19
CI - Costa d'Avorio 18
PL - Polonia 18
TH - Thailandia 17
UZ - Uzbekistan 14
VE - Venezuela 14
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 11
CL - Cile 10
MA - Marocco 10
PY - Paraguay 10
TW - Taiwan 10
AU - Australia 9
AZ - Azerbaigian 9
KE - Kenya 9
CH - Svizzera 8
EG - Egitto 8
LT - Lituania 8
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
PE - Perù 6
TN - Tunisia 6
AL - Albania 5
EU - Europa 5
UY - Uruguay 5
BG - Bulgaria 4
EE - Estonia 4
HN - Honduras 4
JO - Giordania 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
PT - Portogallo 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LU - Lussemburgo 3
NG - Nigeria 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BI - Burundi 2
DK - Danimarca 2
GR - Grecia 2
JM - Giamaica 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
LV - Lettonia 1
Totale 14.990
Città #
Singapore 794
Ashburn 745
Dublin 580
Chandler 520
San Jose 420
Santa Clara 373
Dallas 322
Hong Kong 304
Ho Chi Minh City 287
Jacksonville 272
Beijing 260
Parma 242
Ann Arbor 230
Dearborn 211
Hanoi 211
Boardman 148
Nanjing 145
Johannesburg 141
Focsani 112
Shanghai 106
Los Angeles 100
Princeton 93
San Mateo 91
Council Bluffs 85
Lauterbourg 85
New York 80
Izmir 72
Toronto 63
Vienna 63
Munich 62
Jinan 60
Shenyang 49
São Paulo 49
Buffalo 48
Da Nang 48
Hefei 47
Wilmington 47
Marseille 46
Helsinki 45
Haiphong 43
Bologna 41
Hebei 39
Moscow 38
Nanchang 38
Milan 37
Turku 36
Des Moines 35
Columbus 34
Guangzhou 33
Changsha 32
Rome 32
Tokyo 31
Chicago 30
Brussels 28
Nuremberg 28
Kunming 27
Leawood 27
London 26
Frankfurt am Main 25
Fremont 25
Zhengzhou 25
Jakarta 23
Haikou 22
Tianjin 21
Houston 20
Seattle 20
The Dalles 20
Abidjan 18
Falls Church 18
Jiaxing 18
Redmond 18
Biên Hòa 17
Brooklyn 17
Hải Dương 17
Augusta 16
Dong Ket 16
Montreal 16
Seoul 16
Belo Horizonte 15
Modena 15
Stockholm 15
Atlanta 14
Baghdad 14
Orem 14
Mumbai 13
Phoenix 13
Piacenza 13
Taiyuan 13
Taizhou 13
Trieste 13
Warsaw 13
Ardabil 12
Ardea 12
Denver 12
Tashkent 12
Amsterdam 11
Bremen 11
Chennai 11
Reggio Emilia 11
Las Vegas 10
Totale 8.959
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 473
Ionizing Radiation Effects on Hs 578Bst Microtubules 311
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 311
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 299
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 256
Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies 240
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 238
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 230
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 228
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 213
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes 204
SERS-based methods for the detection of genomic biomarkers of cancer 202
Flexible PBAT-Based Composite Filaments for Tunable FDM 3D Printing 200
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 198
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 192
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 192
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 191
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells 187
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 187
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 184
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 177
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 175
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 173
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 168
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 166
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 165
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 165
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 162
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 160
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 159
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 159
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 159
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 159
Effects of Clusterin knock down on prostate cancer progression in the tramp model 157
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 154
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 151
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 150
Anticancer activity of green tea polyphenols in prostate gland 150
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 150
Clusterin is epigenetically repressed in human prostate cancer cells 149
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 149
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment 149
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 148
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 148
EFFECT OF COLD PLASMA TREATMENT ON THE FUNCTIONAL PROPERTIES OF FRESH-CUT APPLES 148
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 146
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 145
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 145
Clusterin (CLU): From one gene and two transcripts to many proteins 144
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 143
Chemoprevention of human prostate cancer by oral administration of green tea catechins 142
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 140
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 138
Clusterin (CLU) and prostate cancer 136
Clusterin (CLU) and lung cancer 133
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 133
Effect of cold plasma treatment on physico-chemical parameters and antioxidant activity of minimally processed kiwifruit 133
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 129
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 129
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 129
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 127
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 122
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 119
Study on the quality and stability of minimally processed apples impregnated with green tea polyphenols during storage 119
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 118
Clusterin is epigenetically repressed in human prostate cancer. 118
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model 118
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 114
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 114
Sviluppo di un metodo in Real Time PCR per la diagnosi e la prognosi molecolare del carcinoma prostatico umano 112
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 111
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 111
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 110
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 110
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 109
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 108
Effect of plasma exposure time on the polyphenolic profile and antioxidant activity of fresh-cut apples 108
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 107
Platelets contribute to amyloid-b aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release 106
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 105
Il tè verde nella chemoprevenzione oncologica 103
Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update 101
Green tea polyphenols and prostate cancer chemoprevention 101
Role of Clusterin in normal or tumoral bronchial human cells exposed to cigarette smoke 99
Redox Status and Proteostasis in Ageing and Disease 99
Experimental development of a novel molecular tool for human prostate cancer (CaP) diagnosis by RT-qPCR determination of gene expression signature 98
Clusterin: an “enigmatic” protein that turns to a novel tumour-suppressor gene 97
Molecular diagnosis of human prostate cancer (CaP) by RT-qPCR determination of gene expression signature 96
Molecular classification of green tea catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative RT real-time PCR gene profiling 95
Unexpected Absence of Skeletal Responses to Dietary Magnesium Depletion: Basis for Future Perspectives? 94
Nuclear CLU (nCLU) and the fate of the cell 93
Gene signature of TRAMP mice tumors for classification of Green Tea Catechins –sensitive and –resistant prostate cancer 88
HUMAN PROSTATE CANCER PREVENTION BY GREEN TEA CATECHINS: THE CLINICAL TRIAL AND PUTATIVE MOLECULAR MECHANISMS OF ACTION 87
Espressione in forma ricombinante di differenti forme di clusterina 85
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells 82
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 81
Targeting clusterin in prostate cancer 80
Development of a green fluorescent reporter plasmid for the bio-assay of anti-oxidant compounds 78
Prognostic role of clusterin in resected adenocarcinomas of the lung 78
Clusterin Expression and Localization Are Affected by Rituximab and Doxorubicin Treatment in Non-Hodgkin Lymphoma Cells and B Lymphocytes 78
Totale 14.830
Categoria #
all - tutte 47.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022571 22 46 8 16 29 16 71 75 26 44 67 151
2022/20232.055 186 208 155 173 137 232 22 137 669 14 82 40
2023/2024746 63 53 30 24 88 148 49 43 23 54 53 118
2024/20252.768 62 148 133 189 289 312 109 103 342 204 442 435
2025/20265.783 570 403 669 467 790 286 483 205 1.057 455 243 155
Totale 15.174